Profile photo of John E. Flaherty, Esq.

John E. Flaherty, Esq.

Arbitrator Mediator Special Master
New York, NY, United States

About

With over three decades of legal practice, this neutral has focused extensively on complex intellectual property litigation. His background includes serving as a lead trial lawyer in high-stakes patent disputes, particularly within the life sciences and pharmaceutical sectors. He has handled numerous cases involving the Hatch-Waxman Act, biotechnology, and medical devices, as well as matters concerning trade secrets and commercial contracts.

Practice Areas

Business & Commercial Healthcare & Life Sciences Intellectual Property

Professional Experience

Neutral
JAMS
Partner
McCarter & English
LLP
Partner
Gibbons P.C.
Associate
Fitzpatrick
Cella
Harper & Scinto

Publications Leadership

  • Frequent speaker on pharmaceutical patent litigation and Hatch-Waxman topics
  • Author of various articles concerning intellectual property law developments
  • Former Chair of the Intellectual Property Law Section of the New Jersey State Bar Association

Positioning Takeaways

This neutral is established as a specialist in life sciences and pharmaceutical patent disputes, leveraging a deep understanding of both the scientific and legal frameworks of the Hatch-Waxman Act.

License & Certifications

  • Admitted to Bar
  • New Jersey
  • Admitted to Bar
  • New York
  • Admitted to practice
  • U.S. Patent and Trademark Office (USPTO)
  • Admitted to practice
  • U.S. Court of Appeals for the Federal Circuit
  • Admitted to practice
  • U.S. Supreme Court

Education

J.D.
Seton Hall University School of Law
B.S. in Biology
Fairfield University

Distinction

Extensive technical background in biology combined with decades of experience in pharmaceutical and life sciences patent litigation.

Reputation

He is regarded by legal professionals as a highly knowledgeable and effective neutral in the field of intellectual property, noted for his ability to navigate the technical and legal complexities of life sciences disputes.